Axogen Cash vs Total Current Liabilities Analysis

AXGN Stock

USD 5.97 0.02 0.34%

Axogen financial indicator trend analysis is way more than just evaluating Axogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axogen Inc is a good investment. Please check the relationship between Axogen Cash and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Cash vs Total Current Liabilities

Cash vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axogen Inc Cash account and Total Current Liabilities. At this time, the significance of the direction appears to have strong relationship.

The correlation between Axogen's Cash and Total Current Liabilities is 0.74. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Axogen Inc, assuming nothing else is changed. The correlation between historical values of Axogen's Cash and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Axogen Inc are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash i.e., Axogen's Cash and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.74

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cash

Cash refers to the most liquid asset of Axogen Inc, which is listed under current asset account on Axogen Inc balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Axogen customers. The amounts must be unrestricted with restricted cash listed in a different Axogen account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Total Current Liabilities

Total Current Liabilities is an item on Axogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Axogen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Axogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

At this time, Axogen's Selling General Administrative is very stable compared to the past year. As of the 17th of May 2024, Sales General And Administrative To Revenue is likely to grow to 0.36, though Enterprise Value Over EBITDA is likely to grow to (19.41).

	2021	2022	2023	2024 (projected)
Interest Expense	1.4M	624K	8.1M	8.5M
Depreciation And Amortization	4.5M	4.6M	5.6M	5.8M

Interest Expense Depreciation And Amortization

Axogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock
Total Assets		0.7	0.97	0.94	0.93	0.86	0.4	-0.94	0.68	0.85	-0.69	0.69	0.96	0.89	0.71	0.94	0.99	0.82	0.84	0.9	-0.37	0.85	0.88	0.84	0.89	0.88
Short Long Term Debt Total	0.7		0.77	0.76	0.39	0.9	0.86	-0.82	0.49	0.9	-0.8	0.08	0.72	0.65	1.0	0.77	0.69	0.98	0.9	0.37	-0.09	0.86	0.71	0.69	0.67	0.63
Other Current Liab	0.97	0.77		0.97	0.86	0.9	0.46	-0.94	0.72	0.89	-0.71	0.58	0.95	0.86	0.77	0.94	0.96	0.87	0.89	0.82	-0.36	0.88	0.93	0.85	0.87	0.85
Total Current Liabilities	0.94	0.76	0.97		0.82	0.9	0.44	-0.96	0.74	0.89	-0.75	0.5	0.98	0.91	0.75	0.97	0.96	0.87	0.89	0.77	-0.35	0.91	0.87	0.94	0.92	0.9
Total Stockholder Equity	0.93	0.39	0.86	0.82		0.63	0.08	-0.78	0.62	0.63	-0.47	0.86	0.85	0.82	0.4	0.8	0.91	0.55	0.62	0.97	-0.43	0.64	0.77	0.72	0.8	0.81
Property Plant And Equipment Net	0.86	0.9	0.9	0.9	0.63		0.76	-0.9	0.47	1.0	-0.9	0.22	0.89	0.72	0.91	0.93	0.85	0.96	1.0	0.54	-0.3	0.98	0.79	0.87	0.75	0.7
Net Debt	0.4	0.86	0.46	0.44	0.08	0.76		-0.53	-0.02	0.76	-0.79	-0.25	0.42	0.27	0.87	0.52	0.38	0.79	0.75	0.01	0.01	0.69	0.36	0.44	0.3	0.25
Retained Earnings	-0.94	-0.82	-0.94	-0.96	-0.78	-0.9	-0.53		-0.69	-0.9	0.79	-0.49	-0.97	-0.93	-0.81	-0.97	-0.97	-0.9	-0.9	-0.76	0.21	-0.92	-0.83	-0.92	-0.95	-0.92
Cash	0.68	0.49	0.72	0.74	0.62	0.47	-0.02	-0.69		0.46	-0.22	0.59	0.69	0.81	0.47	0.63	0.7	0.57	0.47	0.7	-0.18	0.51	0.78	0.59	0.81	0.81
Non Current Assets Total	0.85	0.9	0.89	0.89	0.63	1.0	0.76	-0.9	0.46		-0.9	0.21	0.88	0.71	0.91	0.93	0.84	0.95	1.0	0.53	-0.3	0.98	0.79	0.87	0.74	0.69
Non Currrent Assets Other	-0.69	-0.8	-0.71	-0.75	-0.47	-0.9	-0.79	0.79	-0.22	-0.9		-0.05	-0.75	-0.59	-0.81	-0.83	-0.71	-0.84	-0.9	-0.35	0.22	-0.9	-0.48	-0.81	-0.62	-0.57
Cash And Short Term Investments	0.69	0.08	0.58	0.5	0.86	0.22	-0.25	-0.49	0.59	0.21	-0.05		0.54	0.65	0.09	0.45	0.66	0.22	0.2	0.93	-0.29	0.21	0.56	0.32	0.59	0.66
Net Receivables	0.96	0.72	0.95	0.98	0.85	0.89	0.42	-0.97	0.69	0.88	-0.75	0.54		0.93	0.72	0.98	0.98	0.84	0.88	0.8	-0.32	0.91	0.85	0.94	0.94	0.91
Common Stock Shares Outstanding	0.89	0.65	0.86	0.91	0.82	0.72	0.27	-0.93	0.81	0.71	-0.59	0.65	0.93		0.64	0.88	0.94	0.75	0.71	0.85	-0.13	0.75	0.77	0.83	0.99	0.99
Non Current Liabilities Total	0.71	1.0	0.77	0.75	0.4	0.91	0.87	-0.81	0.47	0.91	-0.81	0.09	0.72	0.64		0.77	0.69	0.98	0.91	0.38	-0.09	0.86	0.71	0.68	0.66	0.62
Inventory	0.94	0.77	0.94	0.97	0.8	0.93	0.52	-0.97	0.63	0.93	-0.83	0.45	0.98	0.88	0.77		0.96	0.87	0.93	0.73	-0.32	0.96	0.81	0.96	0.9	0.86
Other Stockholder Equity	0.99	0.69	0.96	0.96	0.91	0.85	0.38	-0.97	0.7	0.84	-0.71	0.66	0.98	0.94	0.69	0.96		0.81	0.84	0.88	-0.31	0.87	0.85	0.9	0.94	0.93
Total Liab	0.82	0.98	0.87	0.87	0.55	0.96	0.79	-0.9	0.57	0.95	-0.84	0.22	0.84	0.75	0.98	0.87	0.81		0.95	0.52	-0.17	0.92	0.8	0.79	0.78	0.74
Property Plant And Equipment Gross	0.84	0.9	0.89	0.89	0.62	1.0	0.75	-0.9	0.47	1.0	-0.9	0.2	0.88	0.71	0.91	0.93	0.84	0.95		0.52	-0.29	0.98	0.78	0.88	0.75	0.69
Total Current Assets	0.9	0.37	0.82	0.77	0.97	0.54	0.01	-0.76	0.7	0.53	-0.35	0.93	0.8	0.85	0.38	0.73	0.88	0.52	0.52		-0.35	0.54	0.76	0.63	0.81	0.84
Short Term Debt	-0.37	-0.09	-0.36	-0.35	-0.43	-0.3	0.01	0.21	-0.18	-0.3	0.22	-0.29	-0.32	-0.13	-0.09	-0.32	-0.31	-0.17	-0.29	-0.35		-0.29	-0.33	-0.31	-0.13	-0.11
Intangible Assets	0.85	0.86	0.88	0.91	0.64	0.98	0.69	-0.92	0.51	0.98	-0.9	0.21	0.91	0.75	0.86	0.96	0.87	0.92	0.98	0.54	-0.29		0.76	0.93	0.8	0.74
Other Current Assets	0.88	0.71	0.93	0.87	0.77	0.79	0.36	-0.83	0.78	0.79	-0.48	0.56	0.85	0.77	0.71	0.81	0.85	0.8	0.78	0.76	-0.33	0.76		0.73	0.78	0.76
Accounts Payable	0.84	0.69	0.85	0.94	0.72	0.87	0.44	-0.92	0.59	0.87	-0.81	0.32	0.94	0.83	0.68	0.96	0.9	0.79	0.88	0.63	-0.31	0.93	0.73		0.87	0.82
Common Stock Total Equity	0.89	0.67	0.87	0.92	0.8	0.75	0.3	-0.95	0.81	0.74	-0.62	0.59	0.94	0.99	0.66	0.9	0.94	0.78	0.75	0.81	-0.13	0.8	0.78	0.87		0.99
Common Stock	0.88	0.63	0.85	0.9	0.81	0.7	0.25	-0.92	0.81	0.69	-0.57	0.66	0.91	0.99	0.62	0.86	0.93	0.74	0.69	0.84	-0.11	0.74	0.76	0.82	0.99

Click cells to compare fundamentals

Axogen Account Relationship Matchups

Axogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	154.6M	201.4M	208.0M	195.4M	196.8M	206.7M
Short Long Term Debt Total	3.3M	53.8M	67.5M	67.4M	69.3M	72.8M
Other Current Liab	10.9M	17.4M	16.5M	13.5M	17.1M	18.0M
Total Current Liabilities	20.9M	22.8M	24.3M	23.8M	30.4M	32.0M
Total Stockholder Equity	132.2M	123.1M	112.6M	101.0M	95.7M	100.4M
Property Plant And Equipment Net	18.1M	54.1M	78.1M	93.7M	104.3M	109.5M
Net Debt	(32.4M)	5.0M	34.7M	52.1M	32.3M	33.9M
Retained Earnings	(179.9M)	(203.6M)	(230.6M)	(259.6M)	(281.3M)	(267.2M)
Cash	35.7M	48.8M	32.8M	15.3M	37.0M	38.9M
Non Current Assets Total	19.6M	56.1M	81.0M	97.3M	108.8M	114.3M
Non Currrent Assets Other	(19.6M)	15.7M	(81.0M)	(97.3M)	(87.6M)	(83.2M)
Cash And Short Term Investments	96.5M	104.0M	84.1M	48.8M	37.0M	20.0M
Net Receivables	16.9M	17.6M	18.2M	22.2M	25.1M	26.4M
Common Stock Shares Outstanding	39.2M	40.0M	41.2M	42.1M	42.9M	45.0M
Liabilities And Stockholders Equity	154.6M	201.4M	208.0M	195.4M	196.8M	206.7M
Non Current Liabilities Total	1.6M	55.4M	71.2M	70.6M	70.7M	74.3M
Inventory	13.9M	12.5M	16.7M	18.9M	23.0M	24.2M
Other Stockholder Equity	311.6M	326.4M	342.8M	360.2M	376.5M	395.4M
Total Liab	22.5M	78.2M	95.5M	94.4M	101.2M	106.2M
Property Plant And Equipment Gross	18.1M	54.1M	85.7M	93.7M	118.0M	123.9M
Total Current Assets	135.0M	145.3M	127.0M	98.1M	88.0M	92.4M
Short Term Debt	1.7M	863K	1.8M	1.3M	1.5M	1.5M
Intangible Assets	1.5M	2.1M	2.9M	3.6M	4.5M	4.8M
Other Current Assets	1.7M	4.3M	1.9M	1.9M	2.8M	3.0M
Accounts Payable	8.3M	4.6M	5.9M	9.0M	11.8M	12.4M
Common Stock Total Equity	396K	406K	417K	424K	487.6K	512.0K
Common Stock	396K	406K	417K	424K	431K	452.6K
Other Liab	164K	112K	15K	3K	2.7K	2.6K
Property Plant Equipment	18.1M	38.4M	78.1M	93.7M	107.7M	113.1M
Net Tangible Assets	130.6M	121.1M	109.7M	97.4M	112.0M	58.6M
Long Term Debt	1.6M	52.9M	65.6M	66.1M	46.6M	33.6M
Long Term Debt Total	30K	52.9M	65.6M	66.1M	76.0M	79.8M
Capital Surpluse	311.6M	326.4M	342.8M	360.2M	414.2M	210.4M
Short Long Term Debt	4.7M	28K	1.7M	863K	776.7K	737.9K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:

How To Invest In Axogen

Details

Is Axogen Stock a good investment?

Details

What is Axogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Note that the Axogen Inc information on this page should be used as a complementary analysis to other Axogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Axogen Stock analysis

When running Axogen's price analysis, check to measure Axogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axogen is operating at the current time. Most of Axogen's value examination focuses on studying past and present price action to predict the probability of Axogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axogen's price. Additionally, you may evaluate how the addition of Axogen to your portfolios can decrease your overall portfolio volatility.

	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world

Is Axogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.49)

Revenue Per Share

3.804

Quarterly Revenue Growth

0.129

Return On Assets

(0.06)

Return On Equity

(0.22)

The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axogen Cash vs Total Current Liabilities Analysis

Cash vs Total Current Liabilities

Cash vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Cash

Total Current Liabilities

Axogen fundamental ratios Correlations

Axogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axogen fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Axogen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Other Stockholder Equity	+ 0.99	Total Assets
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.97	Retained Earnings
Inventory	- 0.97	Retained Earnings
Net Receivables	- 0.97	Retained Earnings
Retained Earnings	- 0.96	Total Current Liabilities
Common Stock Total Equity	- 0.95	Retained Earnings
Retained Earnings	- 0.94	Other Current Liab